Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Common genetic driver mutation in NSCLC and their association with thromboembolic events: A retrospective study.

Lung cancer (Amsterdam, Netherlands) - 1 Oct 2022

Lin Miaozhen, Lu Yujuan, Yu Qiwen, Chen Zebin, Peng Jiayu, Cai Xiuyu

Abstract excerpt

This retrospective study aimed to estimate the incidence, risk factors of thromboembolism events (TEs) in non-small cell lung cancer patients harboring common gene mutation, and evaluate a genetic link between oncogenes and the risk of TEs in Asian patients with NSCLC. METHODS: Univariate and multivariate Cox's proportional hazards regression models were used to identify the strongest predictors of TE development...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mutation

Share to Proto-Oncogene Proteins p21(ras)

Share to Reactive Oxygen Species

Share to Thromboembolism

Source

Identifiers

PMID: 35986977
DOI: 10.1016/j.lungcan.2022.06.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Common genetic driver mutation in NSCLC and their association with thromboembolic events: A retrospective study.PMID 35986977Read ↗

Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study.Semantic proximity Read ↗

Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.Semantic proximity Read ↗

Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations.Semantic proximity Read ↗

Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer.Semantic proximity Read ↗

Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study.Semantic proximity Read ↗

The Association Between Thromboembolic Events and ALK, ROS1, RET Rearrangements or EGFR Mutations in Patients With Advanced Lung Adenocarcinoma: A Retrospective Cohort Study.Semantic proximity Read ↗

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.Semantic proximity Read ↗

Cancer Related Venous Thromboembolism for Chinese In-Hospital Cancer Patients: Incidence, Diagnostic Model and Correlation with Driving GenesSemantic proximity Read ↗

Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.Semantic proximity Read ↗

Identification of critical genes and pathways related to venous thromboembolism in non-small cell lung cancer patients using integrated bioinformatics analysisSemantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Incidence, risk factors, and outcome of advanced NSCLC patients receiving antiangiogenic therapy with thromboembolic events: a retrospective cohort studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.